Based on the results of previous studies implicating vinculin as a potential target of anti-endothelial antibodies in SSc, it appears that vinculin may play an essential role in SSc pathophysiology when disrupted by an autoimmune process. This evidence concerns the gene VCL and systemic sclerosis.